Location: Dallas, TX
CIK: 0001617201 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 13, 2026
Total Value: $484M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRCT | PROCEPT BIOROBOTICS CORP | 1,380,000 | $43.41M | 9.0% | $33.86 | -2.1% | COM | 74276L105 |
| GLPG | GALAPAGOS NV | 1,074,112 | $35.12M | 7.3% | $33.19 | — | SPON ADR | 36315X101 |
| JANX | JANUX THERAPEUTICS INC | 2,392,523 | $33.02M | 6.8% | $29.10 | -19.2% | COM | 47103J105 |
| ADCT | ADC THERAPEUTICS SA | 8,477,338 | $29.93M | 6.2% | $3.23 | +25.8% | SHS | H0036K147 |
| KURA | KURA ONCOLOGY INC | 2,529,600 | $26.28M | 5.4% | $9.51 | +10.3% | COM | 50127T109 |
| MGTX | MEIRAGTX HLDGS PLC | 3,209,788 | $25.52M | 5.3% | $6.93 | +19.9% | COM | G59665102 |
| NKTR | NEKTAR THERAPEUTICS | 554,633 | $23.45M | 4.8% | $55.96 | 0.0% | COM NEW | 640268306 |
| VEEV | VEEVA SYS INC | 90,133 | $20.12M | 4.2% | $265.35 | 0.0% | CL A COM | 922475108 |
| ICLR | ICON PLC | 110,000 | $20.04M | 4.1% | $194.71 | -8.5% | SHS | G4705A100 |
| BSX | BOSTON SCIENTIFIC CORP | 210,000 | $20.02M | 4.1% | $100.04 | -2.0% | COM | 101137107 |
| CON | CONCENTRA GROUP HOLDINGS PAR | 891,030 | $17.54M | 3.6% | $20.82 | -4.1% | COMMON STOCK | 20603L102 |
| PHR | PHREESIA INC | 977,152 | $16.53M | 3.4% | $20.63 | 0.0% | COM | 71944F106 |
| FOLD | AMICUS THERAPEUTICS INC | 1,150,000 | $16.38M | 3.4% | $7.87 | +24.9% | COM | 03152W109 |
| SEM | SELECT MED HLDGS CORP | 1,035,086 | $15.37M | 3.2% | $14.11 | -0.1% | COM | 81619Q105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 665,000 | $13.97M | 2.9% | $16.38 | +6.5% | COM | 87164F105 |
| ZYME | ZYMEWORKS INC | 530,393 | $13.97M | 2.9% | $10.69 | +104.1% | COM | 98985Y108 |
| ROIV | ROIVANT SCIENCES LTD | 627,162 | $13.61M | 2.8% | $10.80 | +82.7% | SHS | G76279101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 262,904 | $12.24M | 2.5% | $30.98 | +43.7% | COM | 22663K107 |
| AVTR | AVANTOR INC | 898,499 | $10.3M | 2.1% | $12.31 | 0.0% | COM | 05352A100 |
| STTK | SHATTUCK LABS INC | 2,381,502 | $8.692M | 1.8% | $5.19 | -54.1% | COM | 82024L103 |
| LH | LABCORP HOLDINGS INC | 34,532 | $8.663M | 1.8% | $265.14 | 0.0% | COM SHS | 504922105 |
| WGS | GENEDX HOLDINGS CORP | 55,000 | $7.153M | 1.5% | $137.25 | 0.0% | COM CL A | 81663L200 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 17,109 | $6.803M | 1.4% | $442.56 | 0.0% | COM | 02043Q107 |
| IMVT | IMMUNOVANT INC | 243,404 | $6.187M | 1.3% | $23.65 | -5.7% | COM | 45258J102 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 683,872 | $5.567M | 1.2% | $16.35 | -24.5% | COM NEW | 21833P301 |
| TECX | TECTONIC THERAPEUTIC INC | 235,000 | $4.902M | 1.0% | $31.39 | -40.8% | COM | 878972108 |
| CDNA | CAREDX INC | 250,000 | $4.71M | 1.0% | $17.83 | -6.0% | COM | 14167L103 |
| TERN | TERNS PHARMACEUTICALS INC | 95,000 | $3.838M | 0.8% | $23.11 | 0.0% | COM | 880881107 |
| RCKT | ROCKET PHARMACEUTICALS INC | 743,942 | $2.611M | 0.5% | $13.68 | -75.0% | COM | 77313F106 |
| KIDS | ORTHOPEDIATRICS CORP | 136,741 | $2.429M | 0.5% | $20.84 | -16.0% | COM | 68752L100 |
| OKUR | ONKURE THERAPEUTICS INC | 816,909 | $2.369M | 0.5% | $4.07 | -26.5% | COM CL A | 68277Q105 |
| BBIO | BRIDGEBIO PHARMA INC | 30,000 | $2.295M | 0.5% | $30.67 | +114.0% | COM | 10806X102 |
| ABVX | ABIVAX SA | 17,000 | $2.293M | 0.5% | $134.85 | — | SPONSORED ADS | 00370M103 |
| ACET | ADICET BIO INC | 250,244 | $2.107M | 0.4% | $11.05 | 0.0% | COM NEW | 007002207 |
| TEM | TEMPUS AI INC | 35,000 | $2.067M | 0.4% | $78.23 | 0.0% | CL A | 88023B103 |
| TBI | TRUEBLUE INC | 442,554 | $2.014M | 0.4% | $5.35 | -4.0% | COM | 89785X101 |
| PLRX | PLIANT THERAPEUTICS INC | 1,555,744 | $1.898M | 0.4% | $1.53 | -1.5% | COM | 729139105 |
| RNTX | REIN THERAPEUTICS INC | 442,600 | $513K | 0.1% | $2.99 | -53.9% | COM NEW | 00887A204 |